Sunday, March 26, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home CBRNE

Testimony on DoD’s CBRNE Defense Strategy and Funding

by Global Biodefense Staff
February 11, 2016
DTRA Counter-WMD Research

The dual-hatted director of the Defense Threat Reduction Agency and the USSTRATCOM Center for Combating WMD testified before members of Congress yesterday to lay out a Fiscal Year 2017 budget request and provide examples of how the agency is successfully eliminating the threats posed by chemical, biological, radiological, nuclear and high-yield explosive (CBRNE) weapons of mass destruction.

Kenneth A. Myers appeared at a hearing of the House Armed Services Committee’s Subcommittee on Emerging Threats and Capabilities with two colleagues from the Pentagon, Dr. Arthur T. Hopkins, performing the Duties of the Assistant Secretary of Defense for Nuclear, Chemical, and Biological Defense Programs, and Dr. Wendin D. Smith, Deputy Assistant Secretary of Defense for Countering Weapons of Mass Destruction.

DTRA’s budget request for Fiscal Year 2017 is approximately $1.2 billion, Myers explained, but the agency also executes the $361 million Science and Technology portion of the DoD’s Chemical and Biological Defense Program (CBDP), manages the rest of the CBDP’s $833 million budget, and will soon take over more than $400 million in overseas contingency operations funds requested for the Joint Improvised-Threat Defeat Fund when the Joint IED Defeat Organization merges with DTRA. When those items are included, DTRA’s budget portfolio grows to nearly $3 billion.

“Nearly every year since 2011, we have faced another WMD crisis. These are not necessarily situations that can be easily budgeted or planned,” said Myers. “In these cases, we are forced to surge our efforts and reprioritize resources from more steady-state types of activities.”

The recent events in Syria, Myers said, led to DTRA efforts to help protect key U.S. allies and partners in the Middle East. “This work [the Jordan Border Security Program] is now more important than ever given the rise of ISIS, the clear use of chemical weapons, and the well-known intention of terrorists to utilize any WMD material against the United States and our allies,” said Myers, adding that DTRA’s CBRN Preparedness Program, or CP2, also “provides assistance to the military and civilian first responder organizations of designated Partner Nations, to include Jordan, Lebanon, Iraq, and Turkey, which border Syria.”

Myers also updated the Committee on how the Joint Improvised-Threat Defeat Agency (JIDA) is being brought under DTRA. The 2016 NDA directed that JIDA transition to a military department or existing agency. “I can assure the Committee that the Counter-Improvised Explosive Devices and the CWMD missions will be preserved and enhanced under this transition,” said Myers.

Myers provided details on the agency’s R&D efforts, the Nunn-Lugar Cooperative Threat Reduction Program, and Operations and Maintenance funding before taking questions from Committee members.

Tags: Cooperative Threat ReductionDefense Threat Reduction AgencyEmerging Threats

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Liverpool Synthetic Biology Lab Backed By 2M Award
Policy + Initiatives

Political Interference: White House Launches Framework to Protect Scientific Integrity

January 13, 2023
two soldiers are in head-to-toe hazmat suits with respirator masks while tending to a mannikin on a stretcher
CBRNE

Protection from Biothreats: DOD to Modernize Medical Countermeasures Development

January 10, 2023
Killing Anthrax More Quickly with Hot Air Decontamination
CBRNE

Killing Anthrax More Quickly with Hot Air Decontamination

January 4, 2023
Load More

Latest News

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC